If you are wondering whether Labcorp Holdings is priced attractively right now, starting with a clear look at its valuation can help you decide how it fits into your portfolio. The stock recently ...
In February 2026, Labcorp Holdings Inc. reported past fourth-quarter 2025 sales of US$3,515.8 million and net income of US$164.7 million, alongside full-year 2025 sales of US$13.95 billion and net ...
StockStory.org on MSN
Labcorp (NYSE:LH) misses Q4 CY2025 sales expectations
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On ...
InvestorsHub on MSN
Labcorp tops Q4 profit forecasts but revenue slightly misses
Labcorp Holdings Inc. (NYSE:LH) delivered fourth-quarter adjusted earnings above expectations on Tuesday, though revenue came ...
Laboratory Corp (NYSE: LH) reported third-quarter 2025 adjusted earnings per share of $4.18 on Tuesday, up from $3.50 a year ago, beating the consensus of $4.18. Sales increased 8.6% year-over-year to ...
(LH) on Tuesday reported fourth-quarter profit of $164.7 million. The Burlington, North Carolina-based company said it had ...
BURLINGTON, N.C., Sept. 25, 2025 /PRNewswire/ -- Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will release its financial results for the third ...
Labcorp expanded its partnership with PathAI to offer its FDA-cleared digital pathology platform at the life science giant’s U.S. network of anatomical pathology labs and participating hospitals.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results